UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 316

Sortiert nach

Comparative effectiveness of cisplatin-based and carboplatin-based chemotherapy for treatment of advanced urothelial carcinoma

Annals of oncology, 2012-02, Vol.23 (2), p.406-410

2012

Volltextzugriff (PDF)

Prevalence of adrenal incidentaloma in a contemporary computerized tomography series

Journal of endocrinological investigation, 2006-04, Vol.29 (4), p.298-302

2006

Volltextzugriff (PDF)

Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study

Journal of clinical oncology, 2000-09, Vol.18 (17), p.3068-3077

2000

Volltextzugriff (PDF)

International Expert Consensus on Primary Systemic Therapy in the Management of Early Breast Cancer: Highlights of the Fourth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2010)

Journal of the National Cancer Institute. Monographs, 2011-10, Vol.2011 (43), p.147-151

2011

Volltextzugriff (PDF)

Sorafenib may induce hypophosphatemia through a fibroblast growth factor-23 (FGF23)-independent mechanism

Annals of oncology, 2011-04, Vol.22 (4), p.988-990

2011

Volltextzugriff (PDF)

Long-Term Survival Results of a Randomized Trial Comparing Gemcitabine Plus Cisplatin, With Methotrexate, Vinblastine, Doxorubicin, Plus Cisplatin in Patients With Bladder Cancer

Journal of clinical oncology, 2005-07, Vol.23 (21), p.4602-4608

2005

Volltextzugriff (PDF)

Intermediate Endpoints of Primary Systemic Therapy in Breast Cancer Patients

Journal of the National Cancer Institute. Monographs, 2011-10, Vol.2011 (43), p.142-146

2011

Volltextzugriff (PDF)

Nonsurgical correction of nasal deformity in unilateral complete cleft lip : A 6-year follow-up

Plastic and reconstructive surgery (1963), 1999-09, Vol.104 (3), p.616-630

1999

Volltextzugriff (PDF)

The neuroendocrine phenotype in prostate cancer: basic and clinical aspects

Journal of endocrinological investigation, 2005, Vol.28 (11 Suppl International), p.141-145

2005

Volltextzugriff (PDF)

Adjuvant sequential methotrexate → 5-fluorouracil vs 5-fluorouracil plus leucovorin in radically resected stage III and high-risk stage II colon cancer

British journal of cancer, 2005-01, Vol.92 (1), p.24-29

2005

Volltextzugriff (PDF)

Management of the side-effects of intravenous bisphosphonates: targeting the serum parathyroid hormone elevation

Annals of oncology, 2006-12, Vol.17 (12), p.1854-1855

2006

Volltextzugriff (PDF)

Management of neuroendocrine differentiated breast carcinoma

Breast (Edinburgh), 2004-12, Vol.13 (6), p.527-529

2004

Volltextzugriff (PDF)

Pretreatment haemoglobin levels significantly predict the tumour response to primary chemotherapy in human breast cancer

British journal of cancer, 2003-09, Vol.89 (6), p.977-982

2003

Volltextzugriff (PDF)

Prospective evaluation of mitotane toxicity in adrenocortical cancer patients treated adjuvantly

Endocrine-related cancer, 2008-12, Vol.15 (4), p.1043-1053

2008

Volltextzugriff (PDF)

Potential clinical value of circulating chromogranin A in patients with prostate carcinoma

Annals of oncology, 2001, Vol.12 (suppl-2), p.S153-S157

2001

Volltextzugriff (PDF)

Long-term disease free survival in a patient with metastatic adreno-cortical carcinoma after complete pathological response to chemotherapy plus mitotane

Journal of endocrinological investigation, 2006-06, Vol.29 (6), p.560-562

2006

Volltextzugriff (PDF)

Durable complete remission after weekly docetaxel administration in a patient with mediastinal non-seminomatous germ-cell tumor refractory to cisplatin-based chemotherapy

Annals of oncology, 2003-10, Vol.14 (10), p.1589-1590

2003

Volltextzugriff (PDF)

The clinical management of neuroendocrine tumors with long-acting repeatable (LAR) octreotide: Comparison with standard subcutaneous octreotide therapy

Annals of oncology, 2001, Vol.12 (suppl-2), p.S105-S109

2001

Volltextzugriff (PDF)

International Expert Consensus on Primary Systemic Therapy in the Management of Early Breast Cancer: Highlights of the Fifth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2013)

Journal of the National Cancer Institute. Monographs, 2015-05, Vol.2015 (51), p.90-96

2015

Volltextzugriff (PDF)

p53 expression and disease outcome of breast cancer patients undergoing primary chemotherapy with anthracycline-containing regimens

Annals of oncology, 2003-07, Vol.14 (7), p.1156-1156

2003

Volltextzugriff (PDF)

Somatostatin receptors: from basic science to clinical approach: Unlabeled somatostatin analogues-1: prostate cancer

Digestive and liver disease, 2004-02, Vol.36, p.S60-S67

2004

Volltextzugriff (PDF)

Stage IB Malignant Thymoma in a Lynch Syndrome Patient with Multiple Cancers: Response to Incidental Administration of Oxaliplatin and 5-Fluorouracil

Journal of chemotherapy (Florence), 2006-08, Vol.18 (4), p.433-436

2006

Volltextzugriff (PDF)

The Treatment of Individual Patients Is More Than a Trial

Journal of the National Cancer Institute. Monographs, 2011-10, Vol.2011 (43), p.53-54

2011

Volltextzugriff (PDF)

Repetita iuvant — INTACC (Intergruppo Italiano Terapia Adiuvante Carcinoma del Colon)

Annals of oncology, 2001-09, Vol.12 (9), p.1331-1331

2001

Volltextzugriff (PDF)

European multicentre trial of bromocriptine in cyclical mastalgia

The Lancet (British edition), 1990-01, Vol.335 (8683), p.190-193

1990

Volltextzugriff (PDF)

1 – 25 von 316

Suche als RSS-Feed

Aktive Filter

ThemaAged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(238)
Mit Volltextzugriff
(225)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(146)
Science & Technology
(103)
Life Sciences & Biomedicine
(87)
Female
(78)
Biological And Medical Sciences
(50)
Medical Sciences
(47)
Male
(46)
Oncology
(38)
Middle Aged
(37)
Adult
(33)
Old Medline
(27)
Animals
(26)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(26)
Gynecology. Andrology. Obstetrics
(18)
Mammary Gland Diseases
(15)
Pharmacology. Drug Treatments
(15)
Treatment Outcome
(15)
Rats
(14)
Endocrinology & Metabolism
(13)
Breast Neoplasms - Drug Therapy
(12)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Comparative effectiveness of cisplatin-based and carboplatin-based chemotherapy for treatment of advanced urothelial carcinoma

Prevalence of adrenal incidentaloma in a contemporary computerized tomography series

Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study

International Expert Consensus on Primary Systemic Therapy in the Management of Early Breast Cancer: Highlights of the Fourth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2010)

Sorafenib may induce hypophosphatemia through a fibroblast growth factor-23 (FGF23)-independent mechanism

Long-Term Survival Results of a Randomized Trial Comparing Gemcitabine Plus Cisplatin, With Methotrexate, Vinblastine, Doxorubicin, Plus Cisplatin in Patients With Bladder Cancer

Intermediate Endpoints of Primary Systemic Therapy in Breast Cancer Patients

Nonsurgical correction of nasal deformity in unilateral complete cleft lip : A 6-year follow-up

The neuroendocrine phenotype in prostate cancer: basic and clinical aspects

Adjuvant sequential methotrexate → 5-fluorouracil vs 5-fluorouracil plus leucovorin in radically resected stage III and high-risk stage II colon cancer

Management of the side-effects of intravenous bisphosphonates: targeting the serum parathyroid hormone elevation

Management of neuroendocrine differentiated breast carcinoma

Pretreatment haemoglobin levels significantly predict the tumour response to primary chemotherapy in human breast cancer

Prospective evaluation of mitotane toxicity in adrenocortical cancer patients treated adjuvantly

Potential clinical value of circulating chromogranin A in patients with prostate carcinoma

Long-term disease free survival in a patient with metastatic adreno-cortical carcinoma after complete pathological response to chemotherapy plus mitotane

Durable complete remission after weekly docetaxel administration in a patient with mediastinal non-seminomatous germ-cell tumor refractory to cisplatin-based chemotherapy

The clinical management of neuroendocrine tumors with long-acting repeatable (LAR) octreotide: Comparison with standard subcutaneous octreotide therapy

International Expert Consensus on Primary Systemic Therapy in the Management of Early Breast Cancer: Highlights of the Fifth Symposium on Primary Systemic Therapy in the Management of Operable Breast Cancer, Cremona, Italy (2013)

p53 expression and disease outcome of breast cancer patients undergoing primary chemotherapy with anthracycline-containing regimens

Somatostatin receptors: from basic science to clinical approach: Unlabeled somatostatin analogues-1: prostate cancer

Stage IB Malignant Thymoma in a Lynch Syndrome Patient with Multiple Cancers: Response to Incidental Administration of Oxaliplatin and 5-Fluorouracil

The Treatment of Individual Patients Is More Than a Trial

Repetita iuvant — INTACC (Intergruppo Italiano Terapia Adiuvante Carcinoma del Colon)

European multicentre trial of bromocriptine in cyclical mastalgia

Aktive Filter

Suchergebnisse filtern